Stay updated on VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe study page now indicates that enrollment is suspended and that the enrollment goal is met pending determination of evaluable subjects, replacing the previous recruiting status. The contact information for the study team was removed and a new revision (v3.5.4) was added, along with related date markers.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a newer build of the page. This change does not modify any study content, eligibility criteria, or user-facing functionality.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2; appears to be a minor technical update with no changes to study details or user-facing content.SummaryDifference0.0%

- Check49 days agoChange DetectedRecent updates show March 2026 update dates and submission details for the study record. No substantive changes to eligibility, interventions, or outcomes are visible.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision updated to v3.5.0 and the previous v3.4.3 revision was removed.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.